Department of Infectious Diseases, Prince of Wales Hospital, Randwick, Sydney, NSW, Australia.
Serology and Virology Division (SAViD), Prince of Wales Hospital, Barker Street, Randwick, NSW, Australia.
BMC Infect Dis. 2021 Apr 7;21(1):321. doi: 10.1186/s12879-021-06030-w.
Influenza is a highly contagious respiratory virus with clinical impacts on patient morbidity, mortality and hospital bed management. The effect of rapid nucleic acid testing (RPCR) in comparison to standard multiplex PCR (MPCR) diagnosis in treatment decisions is unclear. This study aimed to determine whether RPCR influenza testing in comparison to standard MPCR testing was associated with differences in antibiotic and antiviral (oseltamivir) utilisation and hospital length of stay in emergency department and inpatient hospital settings.
A retrospective cohort study of positive influenza RPCR and MPCR patients was performed utilising data from the 2017 influenza season. Medical records of correlating patient presentations were reviewed for data collection. An analysis of RPCR versus MPCR patient outcomes was performed examining test turnaround time, antibiotic initiation, oseltamivir initiation and hospital length of stay for both emergency department and inpatient hospital stay. Subgroup analysis was performed to assess oseltamivir use in high risk populations for influenza complications. Statistical significance was assessed using Mann-Whitney test for numerical data and Chi-squared test for categorical data. Odds ratio with 95% confidence intervals were calculated where appropriate.
Overall, 122 RPCR and 362 MPCR positive influenza patients were included in this study. Commencement of antibiotics was less frequent in the RPCR than MPCR cohorts (51% vs 67%; p < 0.01, OR 0.52; 95% CI 0.34-0.79). People at high risk of complications from influenza who were tested with the RPCR were more likely to be treated with oseltamivir compared to those tested with the MPCR (76% vs 63%; p = 0.03, OR 1.81; 95% CI 1.07-3.08). Hospital length of stay was not impacted when either test was used in the emergency department and inpatient settings.
These findings suggest utilisation of RPCR testing in influenza management can improve antibiotic stewardship through reduction in antibiotic use and improvement in oseltamivir initiation in those at higher risk of complications. Further research is required to determine other factors that may have influenced hospital length of stay and a cost-benefit analysis should be undertaken to determine the financial impact of the RPCR test.
流感是一种具有高度传染性的呼吸道病毒,会对患者的发病率、死亡率和病床管理产生临床影响。快速核酸检测(RPCR)与标准多重聚合酶链反应(MPCR)诊断在治疗决策中的效果尚不清楚。本研究旨在确定与标准 MPCR 检测相比,RPCR 流感检测是否与抗生素和抗病毒(奥司他韦)使用以及急诊和住院患者住院时间的差异相关。
利用 2017 年流感季节的数据,对阳性流感 RPCR 和 MPCR 患者进行了回顾性队列研究。对相关患者就诊的病历进行了回顾性数据分析。对 RPCR 与 MPCR 患者的检测结果进行了分析,比较了检测周转时间、抗生素的使用、奥司他韦的使用以及急诊和住院患者的住院时间。进行了亚组分析以评估流感并发症高危人群中奥司他韦的使用情况。对于数值数据,使用曼-惠特尼检验进行统计学显著性评估,对于分类数据,使用卡方检验进行统计学显著性评估。在适当的情况下,计算了比值比及其 95%置信区间。
本研究共纳入 122 例 RPCR 和 362 例 MPCR 阳性流感患者。RPCR 组抗生素的使用频率低于 MPCR 组(51%比 67%;p<0.01,OR 0.52;95%CI 0.34-0.79)。与接受 MPCR 检测的患者相比,接受 RPCR 检测的流感并发症高危人群更有可能接受奥司他韦治疗(76%比 63%;p=0.03,OR 1.81;95%CI 1.07-3.08)。无论是在急诊室还是住院环境中使用哪种检测方法,住院时间都没有受到影响。
这些发现表明,在流感管理中使用 RPCR 检测可以通过减少抗生素的使用并提高奥司他韦在高危并发症患者中的使用,改善抗生素管理。需要进一步研究确定可能影响住院时间的其他因素,并且应该进行成本效益分析以确定 RPCR 检测的经济影响。